New Materials Series C Investors & VC Firms
162 firms in this list, with a median first check of $1M. 7 of them lead rounds. Generated from verified public data and updated continuously.
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
Nysnø Climate Investments
StavangerSeed–Late Stage
11 people
Sambrinvest
CharleroiSeries A–Late Stage
11 people
Spiltan Invest
StockholmSeed–Late Stage$1.6M – $8.6M
8 people
Trident Capital
Palo AltoSeed–Late Stage$5M – $35M
8 people
UMC Capital
TaipeiSeed–Late Stage
11 people
VantagePoint Capital Partners
Santa BarbaraSeed–Late Stage$2M – $100M
8 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
XPV Water Partners
TorontoSeries A–Late Stage
11 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
7 people
Deep Insight
Tel AvivPre-Seed–Late Stage
4 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Samho Green Investment, Inc.
SeoulSeed–Late Stage$500K – $10M
7 people
JAFCO Asia
BeijingSeed–Late Stage
9 people
BASF Venture Capital GmbH
MannheimSeed–Growth$1.1M – $5.4M
6 people
bValue Venture Capital
WarsawSeed–Late Stage$270K – $16.2M
6 people
EnerTech Capital
AmblerSeed–Late Stage$1M – $10M
6 people
Engelhardt Kaupp Kiefer & Co. Management GmbH
StuttgartSeries A–Late Stage$108K – $1.1M
6 people
Midven Ltd.
ManchesterSeed–Late Stage$25.4K – $635K
6 people
Omnivore
Mumbai, MaharashtraSeed–Late Stage
9 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
9 people
Safar Partners
CambridgeSeed–Late Stage
9 people
SIB Innovations- und Beteiligungsgesellschaft
DresdenSeed–Late Stage$54K – $10.8M
6 people
Volvo Group Venture Capital AB
GothenburgSeries A–Late Stage$1.1M – $10.8M
6 people
Related lists
Series C Investors & VC Firms (1701)New Materials Investors & VC Firms (652)New Materials Series A Investors & VC Firms (590)New Materials Seed Investors & VC Firms (560)Series C Investors & VC Firms in United States (555)SaaS Series C Investors & VC Firms (424)Enterprise Software Series C Investors & VC Firms (422)Healthtech Series C Investors & VC Firms (366)Series C Investors & VC Firms in Japan (354)Biotech Series C Investors & VC Firms (342)
Data sourced from public filings and firms' own websites — see our methodology.